Neurothera Labs Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| SCI-110 in the Treatment of Tourette Syndrome (NCT05126888) | Neurothera Labs Inc. | 2026-06-01 |
| SCI-210 in the Treatment of Children and Young Adults With AutismEvaluate the Safety, Tolerability and Efficacy of SCI-210 in Children With Autism Spectrum Disorder (ASD) (NCT05182697) | Neurothera Labs Inc. | 2024-02-21 |
| A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome (NCT03651726) | Neurothera Labs Inc. | 2018-08-01 |
| A Study to Examine the Efficacy of a Therapeutic THX-110 for Obstructive Sleep Apnea (NCT03646552) | Neurothera Labs Inc. | 2018-06-04 |
Track Neurothera Labs Inc. automatically
Every clearance here is in the API, with alerts when new ones post.